Do Androgenic Pattern, Insulin State and Growth Hormone Affect Cardiorespiratory Fitness and Strength in Young Women with PCOS?
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Goodarzi, M.O.; Dumesic, D.A.; Chazenbalk, G.; Azziz, R. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 2011, 7, 219–231. [Google Scholar] [CrossRef]
- Chen, W.; Pang, Y. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites 2021, 11, 869. [Google Scholar] [CrossRef] [PubMed]
- Conte, F.; Banting, L.; Teede, H.J.; Stepto, N.K. Mental health and physical activity in women with polycystic ovary syndrome: A brief review. Sports Med. 2015, 45, 497–504. [Google Scholar] [CrossRef] [PubMed]
- Teede, H.J.; Misso, M.L.; Costello, M.F.; Dokras, A.; Laven, J.; Moran, L.; Piltonen, T.; Norman, R.J.; Andersen, M.; Azziz, R.; et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 2018, 110, 364–379. [Google Scholar] [CrossRef] [PubMed]
- Blair, S.N.; Kohl, H.W.; Paffenbarger, R.S.; Clark, D.G.; Cooper, K.H.; Gibbons, L.W. Physical Fitness and All-Cause Mortality. JAMA 1989, 262, 2395. [Google Scholar] [CrossRef]
- Norman, R.J.; Davies, M.J.; Lord, J.; Moran, L.J. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol. Metab. 2002, 13, 251–257. [Google Scholar] [CrossRef]
- Lim, S.S.; Hutchison, S.K.; Van Ryswyk, E.; Norman, R.J.; Teede, H.J.; Moran, L.J. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst. Rev. 2019. [Google Scholar] [CrossRef]
- Orio, F.; Giallauria, F.; Palomba, S.; Cascella, T.; Manguso, F.; Vuolo, L.; Russo, T.; Tolino, A.; Lombardi, G.; Colao, A.; et al. Cardiopulmonary impairment in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2006, 91, 2967–2971. [Google Scholar] [CrossRef]
- Rissanen, A.-P.E.; Koskela-Koivisto, T.; Hägglund, H.; Koponen, A.S.; Aho, J.M.; Pöyhönen-Alho, M.; Tiitinen, A.; Tikkanen, H.O.; Peltonen, J.E. Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome. Physiol. Rep. 2016, 4, e12719. [Google Scholar] [CrossRef] [PubMed]
- Giallauria, F.; Palomba, S.; Manguso, F.; Vitelli, A.; Maresca, L.; Tafuri, D.; Lombardi, G.; Colao, A.; Vigorito, C.; Orio, F. Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. Clin. Endocrinol. 2008, 68, 88–93. [Google Scholar] [CrossRef]
- Cosar, E.; Köken, G.; Sahin, F.K.; Akgün, L.; Üçok, K.; Genç, A.; Yilmazer, M. Resting metabolic rate and exercise capacity in women with polycystic ovary syndrome. Int. J. Gynecol. Obstet. 2008, 101, 31–34. [Google Scholar] [CrossRef]
- Segal, K.R.; Dunaif, A. Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome. Int J Obes. 1990, 14, 559–567. [Google Scholar] [PubMed]
- Spruit, M.A.; Sillen, M.J.H.; Groenen, M.T.J.; Wouters, E.F.M.; Franssen, F.M.E. New Normative Values for Handgrip Strength: Results From the UK Biobank. J. Am. Med. Dir. Assoc. 2013, 14, 775.e5–775.e11. [Google Scholar] [CrossRef] [PubMed]
- Kim, Y.; White, T.; Wijndaele, K.; Westgate, K.; Sharp, S.J.; Helge, J.W.; Wareham, N.J.; Brage, S. The combination of cardiorespiratory fitness and muscle strength, and mortality risk. Eur. J. Epidemiol. 2018, 33, 953–964. [Google Scholar] [CrossRef] [PubMed]
- Jurca, R.; Lamonte, M.J.; Church, T.S.; Earnest, C.P.; Fitzgerald, S.J.; Barlow, C.E.; Jordan, A.N.; Kampert, J.B.; Blair, S.N. Associations of muscle strength and aerobic fitness with metabolic syndrome in men. Med. Sci. Sports Exerc. 2004, 36, 1301–1307. [Google Scholar] [CrossRef] [PubMed]
- García-Hermoso, A.; Cavero-Redondo, I.; Ramírez-Vélez, R.; Ruiz, J.R.; Ortega, F.B.; Lee, D.-C.; Martínez-Vizcaíno, V. Muscular Strength as a Predictor of All-Cause Mortality in an Apparently Healthy Population: A Systematic Review and Meta-Analysis of Data From Approximately 2 Million Men and Women. Arch. Phys. Med. Rehabil. 2018, 99, 2100–2113.e5. [Google Scholar] [CrossRef] [PubMed]
- Kogure, G.S.; Ribeiro, V.B.; Gennaro, F.; Ganoa de Oliveira, F.; Rui, A.; Miranda-Furtado, C.L.; dos Reis, R.M. Physical Performance Regarding Handgrip Strength in Women with Polycystic Ovary Syndrome. Rev. Bras. Ginecol. Obstet. 2020, 42, 811–819. [Google Scholar] [CrossRef]
- Soyupek, F.; Guney, M.; Eris, S.; Cerci, S.; Yildiz, S.; Mungan, T. Evaluation of hand functions in women with polycystic ovary syndrome. Gynecol. Endocrinol. 2008, 24, 571–575. [Google Scholar] [CrossRef]
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004, 81, 19–25. [CrossRef]
- Legro, R.S.; Arslanian, S.A.; Ehrmann, D.A.; Hoeger, K.M.; Murad, M.H.; Pasquali, R.; Welt, C.K. Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2013, 98, 4565–4592. [Google Scholar] [CrossRef] [Green Version]
- Vermeulen, A.; Verdonck, L.; Kaufman, J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999, 84, 3666–3672. [Google Scholar] [CrossRef] [PubMed]
- Azziz, R.; Carmina, E.; Dewailly, D.; Diamanti-Kandarakis, E.; Escobar-Morreale, H.F.; Futterweit, W.; Janssen, O.E.; Legro, R.S.; Norman, R.J.; Taylor, A.E.; et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil. Steril. 2009, 91, 456–488. [Google Scholar] [CrossRef]
- Matsuda, M.; DeFronzo, R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22, 1462–1470. [Google Scholar] [CrossRef] [PubMed]
- Mozzanega, B.; Mioni, R.; Granzotto, M.; Chiarelli, S.; Xamin, N.; Zuliani, L.; Sicolo, N.; Marchesoni, D.; Vettor, R. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome. Ann. N. Y. Acad. Sci. 2004, 1034, 364–374. [Google Scholar] [CrossRef]
- Mioni, R.; Chiarelli, S.; Xamin, N.; Zuliani, L.; Granzotto, M.; Mozzanega, B.; Maffei, P.; Martini, C.; Blandamura, S.; Sicolo, N.; et al. Evidence for the Presence of Glucose Transporter 4 in the Endometrium and Its Regulation in Polycystic Ovary Syndrome Patients. J. Clin. Endocrinol. Metab. 2004, 89, 4089–4096. [Google Scholar] [CrossRef] [PubMed]
- Borg, G.A. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982, 14, 377–381. [Google Scholar] [CrossRef] [PubMed]
- Fletcher, G.F.; Ades, P.A.; Kligfield, P.; Arena, R.; Balady, G.J.; Bittner, V.A.; Coke, L.A.; Fleg, J.L.; Forman, D.E.; Gerber, T.C.; et al. Exercise Standards for Testing and Training. Circulation 2013, 128, 873–934. [Google Scholar] [CrossRef]
- Sirico, F.; Fernando, F.; Di Paolo, F.; Adami, P.E.; Signorello, M.G.; Sannino, G.; Bianco, A.; Cerrone, A.; Baioccato, V.; Filippi, N.; et al. Exercise stress test in apparently healthy individuals—Where to place the finish line? The Ferrari corporate wellness programme experience. Eur. J. Prev. Cardiol. 2019, 26, 731–738. [Google Scholar] [CrossRef]
- Lewiecki, E.M.; Gordon, C.M.; Baim, S.; Leonard, M.B.; Bishop, N.J.; Bianchi, M.-L.; Kalkwarf, H.J.; Langman, C.B.; Plotkin, H.; Rauch, F.; et al. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 2008, 43, 1115–1121. [Google Scholar] [CrossRef]
- Mathiowetz, V.; Rennells, C.; Donahoe, L. Effect of elbow position on grip and key pinch strength. J. Hand Surg. Am. 1985, 10, 694–697. [Google Scholar] [CrossRef]
- WHO|Global Recommendations on Physical Activity for Health. WHO Published Online First: 2015. Available online: https://www.who.int/dietphysicalactivity/factsheet_recommendations/en/ (accessed on 11 September 2019).
- Bull, F.C.; Maslin, T.S.; Armstrong, T. Global physical activity questionnaire (GPAQ): Nine country reliability and validity study. J. Phys. Act. Health 2009, 6, 790–804. [Google Scholar] [CrossRef] [PubMed]
- Mioni, R.; Cà, A.D.; Turra, J.; Azzolini, S.; Xamin, N.; Bleve, L.; Maffei, P.; Vettor, R.; Fallo, F. Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome. Endocrine 2017, 55, 625–634. [Google Scholar] [CrossRef]
- Costa, E.C.; DE Sá, J.C.F.; Stepto, N.K.; Costa, I.B.B.; Farias-Junior, L.F.; Moreira, S.D.N.T.; Soares, E.M.M.; Lemos, T.M.A.M.; Browne, R.A.V.; Azevedo, G.D. Aerobic Training Improves Quality of Life in Women with Polycystic Ovary Syndrome. Med. Sci. Sports Exerc. 2018, 50, 1357–1366. [Google Scholar] [CrossRef] [PubMed]
- Khatlani, K.; Njike, V.; Costales, V.C. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. Metab. Syndr. Relat. Disord. 2019, 17, 473–485. [Google Scholar] [CrossRef] [PubMed]
- Vigorito, C.; Giallauria, F.; Palomba, S.; Cascella, T.; Manguso, F.; Lucci, R.; De Lorenzo, A.; Tafuri, D.; Lombardi, G.; Colao, A.; et al. Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab. 2007, 92, 1379–1384. [Google Scholar] [CrossRef]
- Thomson, R.L.; Buckley, J.D.; Moran, L.J.; Noakes, M.; Clifton, P.M.; Norman, R.J.; Brinkworth, G.D. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. BJOG An Int. J. Obstet. Gynaecol. 2009, 116, 1242–1250. [Google Scholar] [CrossRef]
- Donà, S.; Bacchi, E.; Moghetti, P. Is cardiorespiratory fitness impaired in PCOS women? A review of the literature. J. Endocrinol. Investig. 2017, 40, 463–469. [Google Scholar] [CrossRef]
- Giallauria, F.; Palomba, S.; De Sio, I.; Maresca, L.; Vuolo, L.; Savastano, S.; Lombardi, G.; Colao, A.; Vigorito, C.; Orio, F. Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS). Clin. Endocrinol. 2009, 70, 394–400. [Google Scholar] [CrossRef]
- Coppini, L.Z.; Waitzberg, D.L.; Campos, A.C.L. Limitations and validation of bioelectrical impedance analysis in morbidly obese patients. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8, 329–332. [Google Scholar] [CrossRef]
- Regensteiner, J.G. Type 2 diabetes mellitus and cardiovascular exercise performance. Rev. Endocr. Metab. Disord. 2004, 5, 269–276. [Google Scholar] [CrossRef]
- Van De Borne, P.; Hausberg, M.; Hoffman, R.P.; Mark, A.L.; Anderson, E.A. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999, 276, R178–R183. [Google Scholar] [CrossRef] [PubMed]
- Valensi, P.; Nguyen, T.N.; Idriss, S.; Cazes, P.; Karam, G.; Paries, J.; Miossec, P.; Attali, J.R. Influence of parasympathetic dysfunction and hyperinsulinemia on the hemodynamic response to an isometric exercise in non-insulin-dependent diabetic patients. Metabolism. 1998, 47, 934–939. [Google Scholar] [CrossRef]
- Nybacka, Å.; Carlström, K.; Ståhle, A.; Nyrén, S.; Hellström, P.M.; Hirschberg, A.L. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome. Fertil. Steril. 2011, 96, 1508–1513. [Google Scholar] [CrossRef]
- Ennour-Idrissi, K.; Maunsell, E.; Diorio, C. Effect of physical activity on sex hormones in women: A systematic review and meta-analysis of randomized controlled trials. Breast Cancer Res. 2015, 17, 139. [Google Scholar] [CrossRef] [PubMed]
- Rolland, Y.; Lauwers-Cances, V.; Cristini, C.; Grandjean, H.; Banks, W.A.; Morley, J.E.; Vellas, B. Disability in obese elderly women: Lower limb strength and recreational physical activity. Obes. Res. Clin. Pract. 2007, 1, 39–51. [Google Scholar] [CrossRef] [PubMed]
- Moghetti, P.; Bacchi, E.; Brangani, C.; Donà, S.; Negri, C. Metabolic Effects of Exercise. Front. Horm. Res. 2016, 47, 44–57. [Google Scholar]
- Li, S.; Zhang, R.; Pan, G.; Zheng, L.; Li, C. Handgrip strength is associated with insulin resistance and glucose metabolism in adolescents: Evidence from National Health and Nutrition Examination Survey 2011 to 2014. Pediatr. Diabetes 2018, 19, 375–380. [Google Scholar] [CrossRef]
- Kogure, G.S.; Silva, R.C.; Picchi Ramos, F.K.; Miranda-Furtado, C.L.; da Silva Lara, L.A.; Ferriani, R.A.; Dos Reis, R.M. Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition. Gynecol. Endocrinol. 2015, 31, 237–242. [Google Scholar] [CrossRef]
- Chikani, V.; Ho, K.K. Department Action of GH on skeletal muscle function: Molecular and metabolic mechanisms. J. Mol. Endocrinol. 2014, 52, R107–R132. [Google Scholar] [CrossRef]
- Premoli, A.C.; Santana, L.F.; Ferriani, R.A.; De Moura, M.D.; Silva De Sá, M.F.; Dos Reis, R.M. Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome. Fertil. Steril. 2005, 83, 1852–1855. [Google Scholar] [CrossRef]
- Chikani, V.; Cuneo, R.C.; Hickman, I.; Ho, K.K.Y. Growth hormone (GH) enhances anaerobic capacity: Impact on physical function and quality of life in adults with GH deficiency. Clin. Endocrinol. 2016, 85, 660–668. [Google Scholar] [CrossRef] [PubMed]
- Strauss, J.F. Some New Thoughts on the Pathophysiology and Genetics of Polycystic Ovary Syndrome. Ann. N. Y. Acad. Sci. 2003, 997, 42–48. [Google Scholar] [CrossRef] [PubMed]
- Rosenfield, R.L.; Ehrmann, D.A. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 2016, 37, 467–520. [Google Scholar] [CrossRef] [PubMed]
- Walters, K.A.; Gilchrist, R.B.; Ledger, W.L.; Teede, H.J.; Handelsman, D.J.; Campbell, R.E. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins. Trends Endocrinol. Metab. 2018, 29, 841–852. [Google Scholar] [CrossRef]
- Holmäng, A.; Svedberg, J.; Jennische, E.; Björntorp, P. Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am. J. Physiol. 1990, 259, E555–E560. [Google Scholar] [CrossRef]
- Moran, L.J.; Misso, M.L.; Wild, R.A.; Norman, R.J. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum. Reprod. Update 2010, 16, 347–363. [Google Scholar] [CrossRef]
- Daan, N.M.P.; Jaspers, L.; Koster, M.P.H.; Broekmans, F.J.M.; De Rijke, Y.B.; Franco, O.H.; Laven, J.S.E.; Kavousi, M.; Fauser, B.C.J.M. Androgen levels in women with various forms of ovarian dysfunction: Associations with cardiometabolic features. Hum. Reprod. 2015, 30, 2376–2386. [Google Scholar] [CrossRef]
- Mario, F.M.; Graff, S.K.; Spritzer, P.M. Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: A cross-sectional study. J. Endocrinol. Investig. 2017, 40, 377–384. [Google Scholar] [CrossRef]
- Woodward, A.; Klonizakis, M.; Broom, D. Exercise and Polycystic Ovary Syndrome. Adv. Exp. Med. Biol. 2020, 1228, 123–136. [Google Scholar] [CrossRef] [PubMed]
- Stepto, N.K.; Patten, R.K.; Tassone, E.C.; Misso, M.L.; Brennan, L.; Boyle, J.; Boyle, R.A.; Harrison, C.L.; Hirschberg, A.L.; Marsh, K.; et al. Exercise Recommendations for Women with Polycystic Ovary Syndrome: Is the Evidence Enough? Sport. Med. 2019, 49, 1143–1157. [Google Scholar] [CrossRef]
Characteristics | PCOS | No PCOS | p |
---|---|---|---|
(n = 31) | (n = 13) | ||
Age (yr) | 27.1 ± 4.8 | 30.6 ± 9.5 | 0.131 |
Weight (kg) | 79.70 ± 18.51 | 90.06 ± 10.54 | 0.070 |
Height (m) | 1.65 ± 0.05 | 1.65 ± 0.06 | 0.748 |
BMI (kg/m2) | 30.3 ± 6.6 | 33.0 ± 4.2 | 0.138 |
Physical Activity Level (METs/min week) | 556 ± 271 | 783 ± 651 | 0.090 |
Testosterone (nmol/L) | 1.94 ± 1.11 | 1.61 ± 1.27 | 0.475 |
Androstenedione (nmol/L) | 10.88 ± 5.10 | 5.40 ± 2.26 | 0.218 |
17-OH-P (nmol/L) | 2.39 ± 1.67 | 1.71 ± 1.26 | 0.501 |
SHBG (nmol/L) | 33.55 ± 15.65 | 52.33 ± 42.16 | 0.460 |
Free Androgen Index | 7.27 ± 5.21 | 3.37 ± 3.25 | 0.079 |
Sum of Androgen (nmol/L) | 14.72 ± 6.96 | 5.79 ± 5.36 | 0.274 |
Growth Hormone (ng/mL) | 2.44 ± 2.78 | 1.32 ± 2.52 | 0.956 |
Insulin Peak (mUI/L) | 118.16 ± 64.39 | 101.08 ± 49.08 | 0.369 |
Insulin Sensitivity (%) * | 76.7 | 53.8 | 0.135 |
HOMA-ir | 2.02 ± 1.40 | 2.70 ± 1.54 | 0.186 |
Fat Mass (kg) | 30.18 ± 11.71 | 38.27 ± 7.17 | 0.078 |
Lean Mass (kg) | 46.58 ± 8.25 | 48.50 ± 5.00 | 0.342 |
Lean Mass Percentage (%) | 64.98 ± 9.28 | 54.58 ± 2.84 | 0.060 |
Lean Mass Dominant Arm (kg) | 21.72 ± 5.17 | 21.52 ± 2.26 | 0.544 |
Characteristics | PCOS | No PCOS | p |
---|---|---|---|
(n = 31) | (n = 13) | ||
VO2max (mL/min) | 2424.3 ± 304.2 | 2216.5 ± 352.0 | 0.060 |
OUES (mL/min∙logL) | 2213.5 ± 346.9 | 1937.2 ± 387.2 | 0.043 |
VO2maxkg (mL/kg/min) | 30.9 ± 7.6 | 24.8 ± 4.1 | 0.010 |
VO2maxFFM (mL/kg/min) | 52.4 ± 8.9 | 45.3 ± 6.2 | 0.018 |
Exercise capacity (METs) | 14.4 ± 2.72 | 12.5 ± 1.72 | 0.019 |
Handgrip (kg) | 28.27 ± 4.33 | 26.13 ± 5.4 | 0.052 |
Hkg | 0.36 ± 0.09 | 0.30 ± 0.08 | 0.009 |
HFFM | 13.03 ± 2.32 | 11.50 ± 1.91 | 0.001 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Baioccato, V.; Quinto, G.; Rovai, S.; Conte, F.; Dassie, F.; Neunhäeuserer, D.; Vecchiato, M.; Palermi, S.; Gasperetti, A.; Bullo, V.; et al. Do Androgenic Pattern, Insulin State and Growth Hormone Affect Cardiorespiratory Fitness and Strength in Young Women with PCOS? Biomedicines 2022, 10, 2176. https://doi.org/10.3390/biomedicines10092176
Baioccato V, Quinto G, Rovai S, Conte F, Dassie F, Neunhäeuserer D, Vecchiato M, Palermi S, Gasperetti A, Bullo V, et al. Do Androgenic Pattern, Insulin State and Growth Hormone Affect Cardiorespiratory Fitness and Strength in Young Women with PCOS? Biomedicines. 2022; 10(9):2176. https://doi.org/10.3390/biomedicines10092176
Chicago/Turabian StyleBaioccato, Veronica, Giulia Quinto, Sara Rovai, Francesca Conte, Francesca Dassie, Daniel Neunhäeuserer, Marco Vecchiato, Stefano Palermi, Andrea Gasperetti, Valentina Bullo, and et al. 2022. "Do Androgenic Pattern, Insulin State and Growth Hormone Affect Cardiorespiratory Fitness and Strength in Young Women with PCOS?" Biomedicines 10, no. 9: 2176. https://doi.org/10.3390/biomedicines10092176